Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2013, Article ID 374170, 20 pages
http://dx.doi.org/10.1155/2013/374170
Review Article

MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma

1Department of Radiology, Spedali Civili, 25100 Brescia, Italy
2Department of Radiology, Istituti Ospitalieri di Cremona, 26100 Cremona, Italy
3Department of Radiology, University of Brescia, Spedali Civili, 25100 Brescia, Italy

Received 4 November 2012; Accepted 24 January 2013

Academic Editor: Paulette Bioulac-Sage

Copyright © 2013 Luigi Grazioli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. La Vecchia and A. Tavani, “Female hormones and benign liver tumours,” Digestive and Liver Disease, vol. 38, no. 8, pp. 535–536, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Prentice, “Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers,” Preventive Medicine, vol. 20, no. 1, pp. 38–46, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Labrune, P. Trioche, I. Duvaltier, P. Chevalier, and M. Odièvre, “Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature,” Journal of Pediatric Gastroenterology and Nutrition, vol. 24, no. 3, pp. 276–279, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Giannitrapani, M. Soresi, E. La Spada, M. Cervello, N. D'Alessandro, and G. Montalto, “Sex hormones and risk of liver tumor,” Annals of the New York Academy of Sciences, vol. 1089, pp. 228–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S. Cappell, “Hepatic disorders severely affected by pregnancy: medical and obstetric management,” Medical Clinics of North America, vol. 92, no. 4, pp. 739–760, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. O. C. Greaves and B. Bhattacharya, “Hepatic adenomatosis,” Archives of Pathology and Laboratory Medicine, vol. 132, no. 12, pp. 1951–1955, 2008. View at Google Scholar · View at Scopus
  7. H. Yoshidome, K. M. McMasters, and M. J. Edwards, “Management issues regarding hepatic adenomatosis,” American Surgeon, vol. 65, no. 11, pp. 1070–1076, 1999. View at Google Scholar · View at Scopus
  8. A. Colli, M. Fraquelli, S. Massironi, A. Colucci, S. Paggi, and D. Conte, “Elective surgery for benign liver tumours,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD005164, 2007. View at Google Scholar · View at Scopus
  9. P. Bioulac-Sage, S. Rebouissou, C. Thomas et al., “Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry,” Hepatology, vol. 46, no. 3, pp. 740–748, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Bioulac-Sage, C. Balabaud, and J. Zucman-Rossi, “Subtype classification of hepatocellular adenoma,” Digestive Surgery, vol. 27, no. 1, pp. 39–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Bioulac-Sage, H. Laumonier, G. Couchy et al., “Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience,” Hepatology, vol. 50, no. 2, pp. 481–489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Zucman-Rossi, E. Jeannot, J. T. Van Nhieu et al., “Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC,” Hepatology, vol. 43, no. 3, pp. 515–524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Lewin, A. Handra-Luca, L. Arrivé et al., “Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings,” Radiology, vol. 241, no. 2, pp. 433–440, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Laumonier, P. Bioulac-Sage, C. Laurent, J. Zucman-Rossi, C. Balabaud, and H. Trillaud, “Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification,” Hepatology, vol. 48, no. 3, pp. 808–818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. V. S. Katabathina, C. O. Menias, A. K. P. Shanbhogue et al., “Genetics and imaging of hepatocellular adenomas: 2011 update,” Radiographics, vol. 31, pp. 1529–1543, 2011. View at Google Scholar
  16. M. Rohrer, H. Bauer, J. Mintorovitch, M. Requardt, and H. J. Weinmann, “Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths,” Investigative Radiology, vol. 40, no. 11, pp. 715–724, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. J. Kim, B. S. Kim, M. J. Kim et al., “Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid andgadobenate dimeglumine, on 3 and 1.5 tesla MRI in the same patient,” Journal of Magnetic Resonance Imaging, 2012. View at Publisher · View at Google Scholar
  18. S. Feuerlein, R. T. Gupta, D. T. Boll, and E. M. Merkle, “Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine,” European Journal of Radiology, vol. 81, no. 9, pp. 2037–2041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. S. Lee, J. Y. Lee, S. H. Kim et al., “Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI,” Journal of Magnetic Resonance Imaging, vol. 33, no. 1, pp. 149–159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Filippone, A. Blakeborough, J. Breuer et al., “Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine,” Journal of Magnetic Resonance Imaging, vol. 31, no. 2, pp. 356–364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Denecke, I. G. Steffen, S. Agarwal et al., “Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI,” European Radiology, vol. 22, pp. 1769–1775, 2012. View at Google Scholar
  22. P. Bioulac-Sage, H. Laumonier, C. Laurent, J. Zucman-Rossi, and C. Balabaud, “Hepatocellular adenoma: what is new in 2008,” Hepatology International, vol. 2, no. 3, pp. 316–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Paradis, A. Champault, M. Ronot et al., “Telangiectatic adenoma: an entity associated with increased body mass index and inflammation,” Hepatology, vol. 46, no. 1, pp. 140–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Bioulac-Sage, S. Rebouissou, A. Sa Cunha et al., “Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver,” Gastroenterology, vol. 128, no. 5, pp. 1211–1218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Mohajer, A. Frydrychowicz, J. B. Robbins et al., “Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid,” Journal of Magnetic Resonance Imaging, vol. 36, no. 3, pp. 686–696, 2012. View at Google Scholar
  26. L. Grazioli, M. P. Bondioni, H. Haradome et al., “Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis,” Radiology, vol. 262, no. 2, pp. 520–529, 2012. View at Google Scholar
  27. P. Bioulac-Sage, J. Frédéric Blanc, S. Rebouissou, C. Balabaud, and J. Zucman-Rossi, “Genotype phenotype classification of hepatocellular adenoma,” World Journal of Gastroenterology, vol. 13, no. 19, pp. 2649–2654, 2007. View at Google Scholar · View at Scopus
  28. O. Bluteau, E. Jeannot, P. Bioulac-Sage et al., “Bi-allelic inactivation of TCF1 in hepatic adenomas,” Nature Genetics, vol. 32, no. 2, pp. 312–315, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Kanematsu, S. Goshima, H. Watanabe et al., “Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review,” Abdominal Imaging, 2012. View at Google Scholar
  30. F. H. Miller, N. Hammond, A. J. Siddiqi et al., “Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions,” Journal of Magnetic Resonance Imaging, vol. 32, no. 1, pp. 138–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. W. Chen, Y. M. Jeng, S. H. Yeh, and P. J. Chen, “p53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia,” Hepatology, vol. 36, no. 4, pp. 927–935, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Farges, N. Ferreira, S. Dokmak, J. Belghiti, P. Bedossa, and V. Paradis, “Changing trends in malignant transformation of hepatocellular adenoma,” Gut, vol. 60, no. 1, pp. 85–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Maillette De Buy Wenniger, V. Terpstra, and U. Beuers, “Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology,” Digestive Surgery, vol. 27, no. 1, pp. 24–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. K. F. Kreitner, M. Thelen, H. Schild et al., “Epidemiologische und klinische aspekte der fokalnodularen hyperplasie der leber,” Deutsche Medizinische Wochenschrift, vol. 112, no. 22, pp. 891–896, 1987. View at Google Scholar
  35. C. Grieser, I. G. Steffen, D. Seehofer et al., “Histopathologically confirmed focal nodular hyperplasia of the liver: Gadoxetic acid-enhanced MRI characteristics,” Journal of Magnetic Resonance Imaging, 2012. View at Publisher · View at Google Scholar
  36. V. Vilgrain, “Focal nodular hyperplasia,” European Journal of Radiology, vol. 58, no. 2, pp. 236–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Hussain, T. Terkivatan, P. E. Zondervan et al., “Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis,” Radiographics, vol. 24, no. 1, pp. 3–17, 2004. View at Google Scholar · View at Scopus
  38. I. R. Wanless, “Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules,” Hepatology, vol. 11, no. 5, pp. 787–797, 1990. View at Publisher · View at Google Scholar · View at Scopus
  39. I. R. Wanless, “Nodular regenerative hyperplasia, dysplasia, and hepatocellular carcinoma,” American Journal of Gastroenterology, vol. 91, no. 5, pp. 836–837, 1996. View at Google Scholar · View at Scopus
  40. J. T. Ames, M. P. Federle, and K. Chopra, “Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver,” Clinical Radiology, vol. 64, no. 12, pp. 1190–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Morana, L. Grazioli, M. A. Kirchin et al., “Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration,” Investigative Radiology, vol. 46, no. 4, pp. 225–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Ichikawa, M. P. Federle, L. Grazioli, J. Madariaga, M. Nalesnik, and W. Marsh, “Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases,” Radiology, vol. 213, no. 2, pp. 352–361, 1999. View at Google Scholar · View at Scopus
  43. T. Ichikawa, M. P. Federle, L. Grazioli, and W. Marsh, “Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging,” Radiology, vol. 217, no. 1, pp. 145–151, 2000. View at Google Scholar · View at Scopus
  44. J. T. Campos, C. B. Sirlin, and J. Y. Choi, “Focal hepatic lesions in Gd-GD-EOB-DTPA enhanced MRI: the atlas,” Insights Imaging, vol. 3, no. 5, pp. 451–474, 2012. View at Google Scholar
  45. C. Sempoux, G. Jibara, S. C. Ward et al., “Intrahepatic cholangiocarcinoma: new insights in pathology,” Seminars in Liver Disease, vol. 31, no. 1, pp. 49–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Guedj, P. Bedossa, and V. Paradis, “Anatomopathologie des cholangiocarcinomes,” Annales de Pathologie, vol. 30, no. 6, pp. 455–463, 2010. View at Google Scholar
  47. Y. Maetani, K. Itoh, C. Watanabe et al., “MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation,” American Journal of Roentgenology, vol. 176, no. 6, pp. 1499–1507, 2001. View at Google Scholar · View at Scopus
  48. R. Manfredi, B. Barbaro, G. Masselli, A. Vecchioli, and P. Marano, “Magnetic resonance imaging of cholangiocarcinoma,” Seminars in Liver Disease, vol. 24, no. 2, pp. 155–164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. E. S. Zafrani and P. Gaulard, “Primary lymphoma of the liver,” Liver, vol. 13, no. 2, pp. 57–61, 1993. View at Google Scholar · View at Scopus
  50. J. Ryan, D. J. Straus, C. Lange et al., “Primary lymphoma of the liver,” Cancer, vol. 61, no. 2, pp. 370–375, 1988. View at Google Scholar · View at Scopus
  51. P. Soyer, B. Van Beers, C. Grandin, J. Pringot, and M. Levesque, “Primary lymphoma of the liver: MR findings,” European Journal of Radiology, vol. 16, no. 3, pp. 209–212, 1993. View at Publisher · View at Google Scholar · View at Scopus
  52. I. Ihse, B. Persson, and S. Tibblin, “Neuroendocrine metastases of the liver,” World Journal of Surgery, vol. 19, no. 1, pp. 76–82, 1995. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Hayashi, J. N. Tkacz, S. Hammond et al., “Gastroenteropancreatic neuroendocrine tumors: multimodality imaging features with pathological correlation,” Japanese Journal of Radiology, vol. 29, no. 2, pp. 85–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Namasivayam, D. R. Martin, and S. Saini, “Imaging of liver metastases: MRI,” Cancer Imaging, vol. 7, no. 1, pp. 2–9, 2007. View at Publisher · View at Google Scholar · View at Scopus